CLINICAL TRIALS PROFILE FOR RAXIBACUMAB
✉ Email this page to a colleague
All Clinical Trials for raxibacumab
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00639678 ↗ | A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects | Completed | Emergent BioSolutions | Phase 3 | 2008-03-01 | To evaluate the safety and tolerability of raxibacumab in healthy subjects. |
NCT00639678 ↗ | A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects | Completed | GlaxoSmithKline | Phase 3 | 2008-03-01 | To evaluate the safety and tolerability of raxibacumab in healthy subjects. |
NCT00639678 ↗ | A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects | Completed | Human Genome Sciences Inc. | Phase 3 | 2008-03-01 | To evaluate the safety and tolerability of raxibacumab in healthy subjects. |
NCT00639678 ↗ | A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects | Completed | Human Genome Sciences Inc., a GSK Company | Phase 3 | 2008-03-01 | To evaluate the safety and tolerability of raxibacumab in healthy subjects. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for raxibacumab
Condition Name
Clinical Trial Locations for raxibacumab
Trials by Country
Clinical Trial Progress for raxibacumab
Clinical Trial Phase
Clinical Trial Sponsors for raxibacumab
Sponsor Name